Reckitt’s Mead Johnson wins defense verdict in Missouri Collins lawsuit

Rocket

Rocket

RKT

0.00
  • Reckitt’s Mead Johnson won a defense verdict in the Collins case in Missouri state court.
  • The case challenged Mead Johnson’s specialized preterm hospital nutrition products, alleging they cause NEC in premature infants.
  • Mead Johnson rejected any causal link to NEC, citing trial testimony on the condition’s multifactorial nature.
  • The company said it will continue to defend against other NEC-related lawsuits.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reckitt Benckiser Group plc published the original content used to generate this news brief on July 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.